Global Biliary Atresia Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 90 pages | ID: G408A665730EEN
QYResearch

Abstracts

This report focuses on the global Biliary Atresia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biliary Atresia Treatment development in North America, Europe and Asia-Pacific.

The key players covered in this study

• AstraZeneca
• Daiichi Sankyo
• Eisai
• Johnson & Johnson
• Novartis
• Pfizer

Market segment by Type, the product can be split into

• Drug Treatment
• Surgery Treatment

Market segment by Application, split into

• Hospital
• Clinic
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• Asia-Pacific

The study objectives of this report are:

• To analyze global Biliary Atresia Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Biliary Atresia Treatment development in North America, Europe and Asia-Pacific.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Biliary Atresia Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Biliary Atresia Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Biliary Atresia Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Drug Treatment
  1.4.3 Surgery Treatment
1.5 Market by Application
  1.5.1 Global Biliary Atresia Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Clinic
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Biliary Atresia Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Biliary Atresia Treatment Industry
    1.6.1.1 Biliary Atresia Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Biliary Atresia Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Biliary Atresia Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Biliary Atresia Treatment Market Perspective (2015-2026)
2.2 Biliary Atresia Treatment Growth Trends by Regions
  2.2.1 Biliary Atresia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Biliary Atresia Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Biliary Atresia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Biliary Atresia Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Biliary Atresia Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Biliary Atresia Treatment Players by Market Size
  3.1.1 Global Top Biliary Atresia Treatment Players by Revenue (2015-2020)
  3.1.2 Global Biliary Atresia Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Biliary Atresia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Biliary Atresia Treatment Market Concentration Ratio
  3.2.1 Global Biliary Atresia Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Biliary Atresia Treatment Revenue in 2019
3.3 Biliary Atresia Treatment Key Players Head office and Area Served
3.4 Key Players Biliary Atresia Treatment Product Solution and Service
3.5 Date of Enter into Biliary Atresia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Biliary Atresia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Biliary Atresia Treatment Forecasted Market Size by Type (2021-2026)

5 BILIARY ATRESIA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Biliary Atresia Treatment Market Size by Application (2015-2020)
5.2 Global Biliary Atresia Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Biliary Atresia Treatment Market Size (2015-2020)
6.2 Biliary Atresia Treatment Key Players in North America (2019-2020)
6.3 North America Biliary Atresia Treatment Market Size by Type (2015-2020)
6.4 North America Biliary Atresia Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Biliary Atresia Treatment Market Size (2015-2020)
7.2 Biliary Atresia Treatment Key Players in Europe (2019-2020)
7.3 Europe Biliary Atresia Treatment Market Size by Type (2015-2020)
7.4 Europe Biliary Atresia Treatment Market Size by Application (2015-2020)

8 ASIA-PACIFIC

8.1 Asia-Pacific Biliary Atresia Treatment Market Size (2015-2020)
8.2 Biliary Atresia Treatment Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Biliary Atresia Treatment Market Size by Type (2015-2020)
8.4 Asia-Pacific Biliary Atresia Treatment Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)

9 KEY PLAYERS PROFILES

9.1 AstraZeneca
  9.1.1 AstraZeneca Company Details
  9.1.2 AstraZeneca Business Overview and Its Total Revenue
  9.1.3 AstraZeneca Biliary Atresia Treatment Introduction
  9.1.4 AstraZeneca Revenue in Biliary Atresia Treatment Business (2015-2020))
  9.1.5 AstraZeneca Recent Development
9.2 Daiichi Sankyo
  9.2.1 Daiichi Sankyo Company Details
  9.2.2 Daiichi Sankyo Business Overview and Its Total Revenue
  9.2.3 Daiichi Sankyo Biliary Atresia Treatment Introduction
  9.2.4 Daiichi Sankyo Revenue in Biliary Atresia Treatment Business (2015-2020)
  9.2.5 Daiichi Sankyo Recent Development
9.3 Eisai
  9.3.1 Eisai Company Details
  9.3.2 Eisai Business Overview and Its Total Revenue
  9.3.3 Eisai Biliary Atresia Treatment Introduction
  9.3.4 Eisai Revenue in Biliary Atresia Treatment Business (2015-2020)
  9.3.5 Eisai Recent Development
9.4 Johnson & Johnson
  9.4.1 Johnson & Johnson Company Details
  9.4.2 Johnson & Johnson Business Overview and Its Total Revenue
  9.4.3 Johnson & Johnson Biliary Atresia Treatment Introduction
  9.4.4 Johnson & Johnson Revenue in Biliary Atresia Treatment Business (2015-2020)
  9.4.5 Johnson & Johnson Recent Development
9.5 Novartis
  9.5.1 Novartis Company Details
  9.5.2 Novartis Business Overview and Its Total Revenue
  9.5.3 Novartis Biliary Atresia Treatment Introduction
  9.5.4 Novartis Revenue in Biliary Atresia Treatment Business (2015-2020)
  9.5.5 Novartis Recent Development
9.6 Pfizer
  9.6.1 Pfizer Company Details
  9.6.2 Pfizer Business Overview and Its Total Revenue
  9.6.3 Pfizer Biliary Atresia Treatment Introduction
  9.6.4 Pfizer Revenue in Biliary Atresia Treatment Business (2015-2020)
  9.6.5 Pfizer Recent Development

10 ANALYST'S VIEWPOINTS/CONCLUSIONS

11 APPENDIX

11.1 Research Methodology
  11.1.1 Methodology/Research Approach
  11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Biliary Atresia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Biliary Atresia Treatment Revenue
Table 3. Ranking of Global Top Biliary Atresia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Biliary Atresia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug Treatment
Table 6. Key Players of Surgery Treatment
Table 7. COVID-19 Impact Global Market: (Four Biliary Atresia Treatment Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Biliary Atresia Treatment Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Biliary Atresia Treatment Players to Combat Covid-19 Impact
Table 12. Global Biliary Atresia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Biliary Atresia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Biliary Atresia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Biliary Atresia Treatment Market Share by Regions (2015-2020)
Table 16. Global Biliary Atresia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Biliary Atresia Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Biliary Atresia Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Biliary Atresia Treatment Players
Table 23. Global Biliary Atresia Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Biliary Atresia Treatment Market Share by Players (2015-2020)
Table 25. Global Top Biliary Atresia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Atresia Treatment as of 2019)
Table 26. Global Biliary Atresia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Biliary Atresia Treatment Product Solution and Service
Table 29. Date of Enter into Biliary Atresia Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Biliary Atresia Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Biliary Atresia Treatment Market Size Share by Type (2015-2020)
Table 33. Global Biliary Atresia Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Biliary Atresia Treatment Market Size Share by Application (2015-2020)
Table 35. Global Biliary Atresia Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Biliary Atresia Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Biliary Atresia Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Biliary Atresia Treatment Market Share (2019-2020)
Table 39. North America Biliary Atresia Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Biliary Atresia Treatment Market Share by Type (2015-2020)
Table 41. North America Biliary Atresia Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Biliary Atresia Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Biliary Atresia Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Biliary Atresia Treatment Market Share (2019-2020)
Table 45. Europe Biliary Atresia Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Biliary Atresia Treatment Market Share by Type (2015-2020)
Table 47. Europe Biliary Atresia Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Biliary Atresia Treatment Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Biliary Atresia Treatment Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Biliary Atresia Treatment Market Share (2019-2020)
Table 51. Asia-Pacific Biliary Atresia Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Biliary Atresia Treatment Market Share by Type (2015-2020)
Table 53. Asia-Pacific Biliary Atresia Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Biliary Atresia Treatment Market Share by Application (2015-2020)
Table 55. AstraZeneca Company Details
Table 56. AstraZeneca Business Overview
Table 57. AstraZeneca Product
Table 58. AstraZeneca Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$)
Table 59. AstraZeneca Recent Development
Table 60. Daiichi Sankyo Company Details
Table 61. Daiichi Sankyo Business Overview
Table 62. Daiichi Sankyo Product
Table 63. Daiichi Sankyo Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$)
Table 64. Daiichi Sankyo Recent Development
Table 65. Eisai Company Details
Table 66. Eisai Business Overview
Table 67. Eisai Product
Table 68. Eisai Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$)
Table 69. Eisai Recent Development
Table 70. Johnson & Johnson Company Details
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Product
Table 73. Johnson & Johnson Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$)
Table 74. Johnson & Johnson Recent Development
Table 75. Novartis Company Details
Table 76. Novartis Business Overview
Table 77. Novartis Product
Table 78. Novartis Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$)
Table 79. Novartis Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Biliary Atresia Treatment Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Biliary Atresia Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drug Treatment Features
Figure 3. Surgery Treatment Features
Figure 4. Global Biliary Atresia Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Biliary Atresia Treatment Report Years Considered
Figure 9. Global Biliary Atresia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Biliary Atresia Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Biliary Atresia Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Biliary Atresia Treatment Market Share by Players in 2019
Figure 14. Global Top Biliary Atresia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biliary Atresia Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Biliary Atresia Treatment Revenue in 2019
Figure 16. North America Biliary Atresia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Biliary Atresia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Asia-Pacific Biliary Atresia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 20. AstraZeneca Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020)
Figure 21. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Daiichi Sankyo Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020)
Figure 23. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Eisai Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020)
Figure 25. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Johnson & Johnson Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020)
Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Novartis Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in Biliary Atresia Treatment Business (2015-2020)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed